Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 24 dec 2013 - 14:52
Statutaire naam Esperite N.V.
Titel Cryo-Save Group N.V. - Cryo-Save Group N.V. - acquisition of the commercial activities of Salveo Biotechnology
Bericht Cryo-Save acquires the commercial activities of Salveo Biotechnology in Switzerland, Spain, Italy, Portugal and Ukraine Frédéric Amar, Non-Executive Director, now deeply involved in the company strategy Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that it has signed an asset sale and purchase agreement to acquire all assets that are exclusively related to the distribution and commercial activities of the umbilical cord blood and umbilical cord tissue cryopreservation business of Salveo Biotechnology S.A., Switzerland and its subsidiaries, effective as of 1 January 2014.

Datum laatste update: 19 april 2024